<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CHLOROPROCAINE HYDROCHLORIDE</span><br/>(klor-oh-proe'kane)<br/><span class="topboxtradename">Nesacaine, </span><span class="topboxtradename">Nesacaine-CE <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">local anesthetic (ester-type)</span><br/><b>Prototype: </b>Procaine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1%, 2%, 3% injection</p>
<h1><a name="action">Actions</a></h1>
<p>Short-acting ester-type local anesthetic similar to procaine. Decreases sodium influx into nerve cells, thus preventing initial
         depolarization, propagation, and conduction of the nerve impulse.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Produces anesthetic effect, but not used for spinal, topical, or IV regional anesthesia.</p>
<h1><a name="uses">Uses</a></h1>
<p>Infiltration anesthesia and for peripheral, sympathetic, and epidural (including caudal) block anesthesia.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Known sensitivity to ester-type anesthetics, bisulfites, parabens (preservative) or PABA; intercurrent use of bupivacaine;
         pregnancy (category C), lactation. Safe use children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Cardiac function impairment; history of drug hypersensitivity; debilitated, older adult, or acutely ill patients; dysrhythmias.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Infiltration and Nerve Block</span><br/><span class="rdage">Adult:</span> <span class="rdroute"></span> 12% solution: max of 800 mg without epinephrine, 1 g with epinephrine<br/><br/><span class="indicationtitle">Caudal and Epidural Block (Without Preservatives)</span><br/><span class="rdage">Adult:</span> <span class="rdroute"></span> 23% solution: max of 800 mg without epinephrine, 1 g with epinephrine<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Caudal/Epidural</span><br/><ul>
<li>A test dose (3 mL of 3% solution or 5 mL of 2% solution) may be given before epidural use to check for intravascular
            or subarachnoid injection. Signs of intravascular injection: "epinephrine response" (tachycardia, circumoral pallor,
            palpitations, nervousness). Signs of subarachnoid injection: motor paralysis and extensive sensory anesthesia.
         </li>
<li>If patient is moved with potential displacement of epidural catheter, test dose is repeated. At least 5 min should elapse
            between each test dose. Total dose for anesthesia is administered in fractional doses.
         </li>
<li>Nesacaine formulation incorporates parabens (preservative) and sodium bisulfite; Nesacaine-CE is preservative-free but incorporates
            sodium bisulfite. Both parabens and bisulfites may initiate an allergic reaction in some individuals. Determine patient's
            sensitivity before administration of drug.
         </li>
<li>Chloroprocaine is incompatible with alkali hydroxides and their carbonates: soaps, iodine, iodides, silver salts. Avoid use
            of any of these agents for skin or mucous membrane disinfection before chloroprocaine administration.
         </li>
<li>Do not administer solution that is colored. Discard partially used solutions that are preservative-free.</li>
<li>Store vials at 15°30° C (59°86° F); protect from freezing and from direct light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span>
<b>Sneezing</b>, <span class="speceff-life">anaphylactoid reactions</span>. <span class="typehead">CV:</span> Myocardial depression, hypotension, arrhythmias, bradycardia, <span class="speceff-life">cardiac arrest</span>. <span class="typehead">GI:</span> Nausea, vomiting. <span class="typehead">CNS:</span> Anxiety, nervousness, tremors, sedation, circumoral paresthesia, convulsions followed by drowsiness, <span class="speceff-life">respiratory arrest</span>. <span class="typehead">Skin:</span> Cutaneous lesions of delayed onset; urticaria. <span class="typehead">Special Senses:</span> Blurred or double vision, tinnitus. <span class="typehead">Other:</span> With caudal or epidural anesthesia: urinary retention, fecal or urinary incontinence, slowing of labor and increased incidence
      of forceps delivery, headache, backache, edema, status asthmaticus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May antagonize effects of <span class="classification">sulfonamides</span>; increased risk of hypotension with <span class="classification">mao inhibitors</span>, <span class="classification">antihypertensive agents</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 612 min. <span class="typehead">Duration:</span> 3060 min without epinephrine; 6090 min with epinephrine. <span class="typehead">Metabolism:</span> Hydrolyzed by plasma pseudocholinesterases. <span class="typehead">Elimination:</span> Excreted by kidneys. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor vital signs throughout period of drug use.</li>
<li>Have immediately available resuscitation equipment, oxygen, resuscitative drugs, and vasopressors when chloroprocaine is in
            use.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report urinary retention or urinary or fecal incontinence.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>